Showing results (11-20 of 135) with videos related to
Sort By:
Pageof 14
British Journal of Pharmacology|August 26, 2010
Are there functional β₃-adrenoceptors in the human heart?Martin C Michel, Sian E Harding, Richard A BondBritish Journal of Pharmacology|August 1, 2012
The case for induced pluripotent stem cell-derived cardiomyocytes in pharmacological screeningJaffar M Khan, Alexander R Lyon, Sian E HardingBritish Journal of Pharmacology|February 6, 2004
Overexpression of beta 1-adrenoceptors in adult rat ventricular myocytes enhances CGP 12177A cardiostimulation: implications for 'putative' beta 4-adrenoceptor pharmacologyClive J Lewis, Haibin Gong, Morris J Brown, et al.Pharmacology & Therapeutics|November 4, 2006
The human embryonic stem cell-derived cardiomyocyte as a pharmacological modelSian E Harding, Nadire N Ali, Marta Brito-Martins, et al.Nanotoxicology|September 23, 2010
Assessment of cellular toxicity of TiO2 nanoparticles for cardiac tissue engineering applicationsHedeer Jawad, Aldo R Boccaccini, Nadire N Ali, et al.Molecular and Cellular Biochemistry|October 25, 2003
Contractile effects of adenovirally-mediated increases in SERCA2a activity: a comparison between adult rat and rabbit ventricular myocytesBabar Chaudhri, Federica del Monte, Roger J Hajjar, et al.Cardiovascular Research|January 25, 2013
Spatial control of the βAR system in heart failure: the transverse tubule and beyondJulia Gorelik, Peter T Wright, Alexander R Lyon, et al.British Journal of Clinical Pharmacology|June 19, 2012
Stem cell-derived endothelial cells for cardiovascular disease: a therapeutic perspectiveDaniel M Reed, Gabor Foldes, Sian E Harding, et al.American Journal of Physiology. Heart and Circulatory Physiology|October 22, 2002
Interaction between increased SERCA2a activity and beta -adrenoceptor stimulation in adult rabbit myocytesBabar Chaudhri, Federica Del Monte, Roger J Hajjar, et al.NPJ Regenerative Medicine|January 6, 2018
The adaptive immune response to cardiac injury-the true roadblock to effective regenerative therapies?Susanne Sattler, Paul Fairchild, Fiona M Watt, et al.Pageof 14